Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
about
Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in manInvolvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophilsPlatelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretionBinding and metabolism of platelet-activating factor by human neutrophilsThrombin stimulates the adherence of neutrophils to human endothelial cells in vitroOccupancy of platelet receptors for platelet-activating factor in patients with septicemia.Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit.Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.Glucocorticoid protection against PAF-acether toxicity in mice.Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation.Mast cells in allergic diseases and mastocytosis.Immunologic mechanisms of parenchymal lung injury.The human lung mast cell.Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.Protection of platelet-activating factor-induced acute renal failure by BN 52021.Anaphylactic actions of platelet-activating factor.Gastric mucosal damage induced by local intra-arterial administration of Paf in the ratEffects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis.Characterization of the Phospholipid Platelet-Activating Factor As a Mediator of Inflammation in Chickens.
P2860
Q28326803-6A2F8D4E-F465-4C5A-B914-DC7992AE8749Q33496841-386661F3-7CC4-4965-99BA-CE75F09C70D0Q34358961-0A7BE9F6-87E2-4AEB-8D73-C3189168BC3BQ34409413-B27CA235-70CD-4485-89C4-9D7A576E0352Q34532662-A37C7ABC-AA91-4DBB-BC65-8ADB9A43900DQ34569233-BFA5907F-9AAE-475F-82B7-EE1CBB389BD0Q34573417-0BA1573E-B345-4C14-A8C7-D4655DC774F7Q35203229-50BFE2D2-6AA1-40FF-BCE3-7F64BA555614Q35835401-C8ECF5C7-5DB1-451C-BA32-938733F0EC62Q35885820-896345F3-506D-45EE-82FD-A6E2E6C5018EQ36097813-5F57A377-5D9B-49A6-8428-54A213C37BE1Q37603754-78FDCA9B-958C-4F71-B99F-1C769B4A6722Q39399589-ED898B3B-A007-467A-918A-FCF6C54BC716Q40117355-419E6586-CC3A-41BD-AD8C-F0F7601BDEF1Q40212548-08C0E532-4376-49BE-B6E8-8A19F9482A40Q40597978-9D8C4585-2155-44E8-833C-A5D27D976456Q41202814-E1406A2F-111B-419E-A108-102753195CD5Q41564083-D175B2AA-FA3A-4971-8595-015A526E50BFQ41810357-B76CD180-D470-411E-96E5-A5FA61B729BAQ41824010-D583DDD4-9F8B-4128-BFCC-1FE8E1B94D9AQ42075404-807FD656-B4E0-4DF2-9AD7-8B4A51149E90Q42577082-445C01BE-DF6C-4ADF-9F5C-5907DAEAA94EQ42710783-EB467DAA-46CB-4EF6-B778-CA7211A1D906Q42735338-DF02BD57-6CC0-425B-A464-08033EFAE0E2Q42848383-DA48F83C-AE7C-44B8-94D0-0FB4B1634CF8Q43185671-DE169478-0A8D-4C98-98DA-544B6E3BF903Q50074595-0D1EBAF3-C10A-4E2A-9E53-705F7D197FC1
P2860
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@ast
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@en
type
label
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@ast
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@en
prefLabel
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@ast
Pathobiology of the intravenou ...... g factor (PAF), in the rabbit.
@en
P2093
P1476
Pathobiology of the intravenou ...... ng factor (PAF), in the rabbit
@en
P2093
Demopoulos CA
Hanahan DJ
McManus LM
Pinckard RN
P304
P407
P577
1980-06-01T00:00:00Z